The anticryptosporidial activity of four macrolides alone and in combination with other antimicrobial agents was investigated against ten clinical isolates of Cryptosporidium parvum recovered from stools of AIDS patients. The susceptibility tests were performed by inoculation of the protozoa on to cell monolayers and determining the parasite count after 72 h incubation at 37°C. The culture medium was supplemented with Dulbecco's modified Eagle's medium containing serial dilutions of azithromycin, clarithromycin, roxithromycin, spiramycin, alone or in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine. Most of the agents had an inhibitory effect on parasite growth, but only at high concentrations. No agent was able to inhibit parasite growth completely, even at the highest concentrations used. The more effective agents, azithromycin, clarithromycin, roxithromycin, minocycline and pyrimethamine, produced no more than a 13.1-27.8% reduction in oocyst count and no more than a 15.1-35.7% in schizont count. Positive interaction was clearly demonstrated when macrolides were tested in combination with minocycline or pyrimethamine.
Introduction
Cryptosporidium parvum is a major cause of diarrhoeal disease in both immunocompetent and immunocompromised subjects. To date, effective therapy for this protozoan infection has been elusive (Portnoy et al., 1984) . Many antimicrobial agents have been tested in vitro, in animals or in humans. Anecdotal reports suggest a favourable clinical response to treatment with spiramycin, but additional data indicate that it is not consistently effective against C. parvum (McDonald et al., 1990; Weikel et al., 1991) .
A recent study (Rohlman et al., 1993) demonstrated that the hydroxynaphthoquinone atovaquone has no demonstrable efficacy in a murine model at serum concentrations equal to, or in excess of, those obtained in humans during atovaquone treatment of Pneumocystis carinii infection.
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In a placebo-controlled, double blind trial (White, 1994) performed to clarify whether paromomycin has clinical and anti-parasitic activity in AIDS-associated cryptosporidiosis, there was improved gastrointestinal function and decreased oocyst excretion in patients treated with this agent. However, paramomycin had a poor anticryptosporidial effect in a dexamethasone-treated rat model (Verdon et al., 1994) . It has been suggested (Rehg, 1994 ) that paramomycin has limited usefulness either in the large intestine or biliary duct infection due to C. parvum: paramomycin treatment was effective in the experimental infection of the ileum but not of the caecum.
In the last few years other macrolide antibiotics (azithromycin, clarithromycin, erithromycin, oleandomycin and roxithromycin) have been introduced (Rehg, 1991; Petersen, 1992; Vargas et al., 1993; Cama et al., 1994) . Azithromycin has been reported to be effective as suppresive therapy for cryptosporidiosis in steroid-immunosuppressed rodents (Regh, 1991; Petersen, 1992) . A recent note described a prompt clinical improvement in two children with cancer and severe Cryptosporidium-associated diarrhoea after administration of azithromycin (Vargas et al., 1993) .
Clarithromycin and its metabolite 14-OH clarithromycin have both been reported to have anti-cryptosporidial activities (Cama et al., 1994) . In a mouse model of infection these authors showed significant parasite reduction in the ileum as well as in the liver, although eradication of the parasite was not achieved.
A wide variety of drugs, including antiparasitic agents like pyrimethamine, artemisin and trimethoprim-sulphamethoxazole, have not shown efficacy against C. parvum (Petersen, 1992; Fayer & Ellis, 1994) . However, dapsone, minocycline and dihydrofolate reductase inhibitors have good in-vitro and in-vivo activity against coccidia (Derovin & Chastang, 1989; Derouin et al. 1992; Chio & Queener, 1993; Romand, Pudney & Derouin, 1993; Chang et al., 1994; Lacassin et al., 1995) .
In this work, we investigated the in-vitro activity of four macrolides (azithromycin, clarithromycin, roxithromycin and spiramycin) in combination with pyrimethamine, dapsone, artemisin or minocycline against ten clinical isolates of C. parvum.
Materials and methods

Parasite preparation
Oocysts of C. parvum were isolated from stools of ten different patients with AIDS who had been diagnosed with active cryptosporidiosis. Stool specimens were stored at 4°C in 2.5% (w/v) potassium dichromate (Sigma-Aldrich, Milan, Italy) for up to four months until processing. Stools were homogenized in physiological saline and filtered through a metal sieve with a mesh size of 400 /<m to remove coarse debris. Fatty material was removed by ether sedimentation: stools were separated into 9 mL aliquots and ether (1 mL) was mixed with each aliquot which was then centrifuged (200g for 20 min). The supernatant with the fatty plug was discarded. Successively, oocysts were purified and concentrated by flotation in Sheather's sugar solution. The upper layer, which contained most of the oocysts, was removed and collected. Contaminating bacteria were eliminated by three washes in 10 mL of sterile distilled water followed by two washes in 0.05% sodium hypochlorite and finally by incubation in phosphate buffered saline (PBS) containing penicillin G (2000 U/mL), streptomycin (2000 mg/L), and amphotericin-B (10 mg/L), for 4 h at 37°C. Excystation of sporozoites was achieved by incubating oocysts in PBS (Bio-Whittaker, USA) containing 0.25% trypsin (Sigma-Aldrich, Milan, Italy) and 0.75% sodium taurocholate for 60 min at 37°C. Free sporozoites were pelleted by centrifugation (200g for 20 min), resuspended in Dulbecco's modified Eagle's medium (DMEM) (Bio-Whittaker, USA), counted in a haemocytometer, and aliquoted for culture.
Cell cultures
A-549 cells from human lung carcinoma (Bio-Whittaker, USA) were maintained in 25 cm 2 tissue culture flasks. Medium consisted of DMEM with 10% fetal calf serum (Bio-Whittaker, USA), 1% L-gJutamine (Bio-Whittaker, USA), 20 mM N-2-hydroxyethylpiperaxine-N-ethanesulphonic acid (HEPES) (Sigma-Aldrich, Milan, Italy) penicillin G (100 U/mL), streptomycin (100 mg/L) and amphotericin B (0.5 mg/L). Cells were lifted from the surface of flasks by using a solution of 0.25% trypsin and 0.53 mM EDTA in PBS; then they were quantitated using a haemocytometer. Forty-eight hours prior to parasite inoculation, A549 cells were plated into 35 mm diameter tissue culture plates at a concentration of 10 5 viable cells in a total volume of 5mL. Viability was assessed by trypan blue exclusion.
Infection of cell with C. parvum
Culture were initiated by adding W sporozoites in a volume of 50 /iL of medium to an adherent layer of 50-70% confluent A549 cells. A confluence of more than 70% made it difficult to distinguish the Cryptosporidium schizonts, when Giemsa stain were used to observe the asexual stages within cells. After incubation for 4 h at 37°C in 5% CO 2 to allow attachment and penetration of sporozoites, the monolayers were washed with DMEM to remove non invasive sporozoites, residual oocysts and nonadherent epithelial cells, and 5 mL of new growth medium with or without antimicrobial agents was added. Infected cell cultures were kept at 37°C in 5% CO 2 throughout the study.
Antimicrobial agents
Azithromycin (Pfizer/Roerig, Rome, Italy), clarithromycin (Abbott, Rome, Italy), roxithromycin (Roussel Pharma, Milan, Italy), spiramycin (Sigma-Aldrich, Milan, Italy), atovaquone (Wellcome Italia, Rome, Italy) and pyrimethamine (Sigma-Aldrich, Milan, Italy) were dissolved in 50% methanol-50% acetone at a concentration of 1 mg/mL. Minocycline (Sigma-Aldrich, Milan, Italy) was dissolved in distilled water at a concentration of 1 mg/mL. Artemisin (Sigma-Aldrich, Milan, Italy) and dapsone (Sigma-Aldrich, Milan, Italy) were initially dissolved in dimethylsulphoxide (SigmaAldrich, Milan, Italy) at a concentration of 5 mg/mL and then diluted further to a concentration of 1 mg/mL in ethanol.
In-vitro studies
Serial dilutions of each agent were prepared in DMEM such that the addition of 100 //L of each dilution to a culture plate produced the required final concentration. pyrimethamine, 0.005, 0.05 and 0.5 mg/L. The highest concentrations of each of these five agents are close to those attainable in vivo. Preliminary experiments indicated that the final concentrations of methanol, acetone, dimethylsulphoxide and ethanol used in the dilution of drugs did not inhibit the growth of C. parvum. In experiments to test drug interactions, four concentrations of each macrolide (2, 8, 16 and 32 mg/L) and the three above-mentioned concentrations of each other agent were tested in triplicate. C. parvum sporozoites were added at a concentration of 10 5 sporozoites per plate. The monolayers were incubated for 72 h at 37 C C in 5% CO 2 , then the medium was removed and, following four washes in fresh medium to remove free oocysts and nonadherent epithelial cells, they were fixed with 75% methanol and stained by Giemsa stain to evaluate the presence of Cryptosporidium schizonts within cells and by a modified acid fast stain to visualize either intra-and extracellular oocysts (Ma & Soave, 1983; Flanigan et al., 1991) . A 72 h reading was selected since it has been shown that this period is necessary to allow the development of either asexual and sexual stages of C. parvum (Current & Haynes, 1984) .
Analysis of results
The anti-cryptosporidial activity of each agent and combination was evaluated by comparing the parasite count from plates with antimicrobial-supplemented medium with that from control plates without antimicrobials. The number of parasites was calculated as the mean ± standard deviation of the mean of the number of schizonts and oocysts observed in three monolayers of each of the ten isolates exposed to the same concentration of drug, by microscopic examination of 50 fields under oil immersion (x 1000 magnification) from each monolayer.
Each drug concentration was defined as inhibitory if it caused a significant decrease in parasite count when compared with control plates. The significance of differences was evaluated by Student's /-test. In addition, to assess the efficacy of drug combinations, the significance of differences between results obtained by testing the macrolides in combination were compared by Student's /-test with those of control plates. A P value of ^0.05 was considered significant.
Results
Macrolides
These agents appeared to have no effect on C. parvum at the lower concentrations used. Nevertheless, azithromycin and clarithromycin concentrations of ;> 16 mg/L and a roxithromycin concentration of 32 mg/L were inhibitory (P < 0.05). Azithromycin at concentrations of 16 and 32 mg/L caused a decrease in both oocyst (17.8% and 27.8% respectively) and schizont counts (21.7% and 35.7%). Clarithromycin, at the same concentrations, also caused a decrease in oocyst (15.3% and 21.2%) and schizont counts (25.4% and 32.5%). Roxithromycin and spiramycin at a concentration of 32 mg/L caused a decrease in oocyst counts of 15.1 % and 9.2%, and in schizont counts of 25.1 % and 17.2%, respectively. Results are summarized in Table I . 
Artemisin, atovaquone, and dapsone
Neither artemisin, atovaquone nor dapsone had significant inhibitory effects on C. parvum (P > 0.05; data not shown). Thus, at the highest concentrations used, these agents caused minor decreases in the mean numbers of oocysts (1.3%, 7.8% and 4.1%, respectively) and schizonts (1.6%, 9.1% and 5.0%, respectively).
Minocycline
A significant inhibitory effect on parasite growth was noted for minocycline at a concentration of 20 mg/L, (P < 0.05), with a mean decrease of 14.3% in oocyst count and of 15.1% in schizont count (Tables II to V) .
Pyrimethamine
A pyrimethamine concentration of 0.5 mg/L was inhibitory to C. parvum (P < 0.05), with a mean decrease of oocysts and schizonts of 13.1% and 13.7%, respectively (Tables  II to V) .
Antimicrobial combinations
To assess any potential synergic effect, we performed experiments in which both inhibitory concentrations (P <, 0.05) and noninhibitory concentrations (P > 0.05) of each agent were tested. Our data showed that the activity of macrolides remained virtually unchanged either when they were tested alone or in combination with artemisin, atovaquone or dapsone. In contrast, their activity was significantly improved 44.5% (<0.001) 'P <. 0.05 is statistically significant. when they were combined at noninhibitory concentrations with minocycline 2 mg/L or pynmethamine 0.05 mg/L (Tables II to V) . Azithromycin 32 mg/L in combination with minocycline 20 mg/L showed the highest activity with a decrease of 57..2% in oocyst count and 61.5% in schizont count (Table II) . Table IV 
Discussion
In our study an in-vitro culture system for C. parvum was used to measure the anticryptosporidial activity of nine antimicrobial agents. Most of the agents studied had some inhibitory effect on parasite growth, but only at high concentrations. In addition, no agent was able to inhibit parasite growth completely, even at the highest concentrations used. The more effective agents, azithromycin, clarithromycin, roxithromycin, minocycline and pyrimethamine, produced no more than a 13.1-27.8% and a 15.1-35.7% reduction in oocyst and schizont development respectively, while artemisin, atovaquone and dapsone were scarcely effective.
To assess any potential interaction, we performed experiments in which inhibitory and noninhibitory concentrations of each macrolide were tested in combination with the other agents. Since no agent was able to inhibit parasite count completely, we could not evaluate drug interaction by MICs and FIC indices. Consequently, we calculated the statistical significance of the differences in the mean numbers of oocysts or schizonts detected after 72 h incubation in antibiotic-free medium and in the presence of drug combinations.
Azithromycin 8 mg/L, clarithromycin 8 mg/L, roxithromycin 16 mg/L and spiramycin 16 mg/L in combination with minocycline 2 mg/L or pyrimethamine 0.05 mg/L yielded a significant reduction of oocysts count as well (Tables II to V) . No positive interaction could be demonstrated between macrolides and artemisin, atovaquone or dapsone (data not shown). These results suggest that macrolides, minocycline and pyrimethamine are somewhat effective in inhibiting parasite growth at concentrations close to those achievable in vivo.
The reason why macrolidies have positive interaction with minocycline or pyrimethamine is unclear. The antibacterial activity of the macrolides and tetracyclines is known to result from their ability to inhibit protein synthesis by binding to the transpeptidation site of the larger ribosomal subunit, thus it is logical that these agents should also affect C. parvum by inhibiting protein synthesis. In recent reports (Cantin & Chamberland, 1993; Pfefferkorn & Borotz, 1994) azithromycin was shown to produce the specific inhibition of protein synthesis in Toxopiasma gondii, another coccidial agent. Nevertheless, the authors concluded that protein synthesis on the cytoplasmic ribosomes of T. gondii is unlikely to be the target of azithromycin. They assumed that protein synthesis in mitochondria, that are thought to have originated from bacteria, is a reasonable alternative target for macrolides. In addition. T. gondii and other apicomplexans have a second extrachromosomal genome, a 35 kb circular genome related to plasmids (Pfefferkorn & Borotz, 1994) . Like the mitochondrial genome, the 35-kb genome encodes rRNAs and thus probably has its own ribosomes. Since plasmids are thought to have their origin in cyanobacteria (Schwartz & Dayhoff, 1978) , their protein synthesis could be sensitive to macrolides and tetracyclines.
On the other hand, pyrimethamine is a specific inhibitor of the dihydrofolate reductase of many microorganisms, an enzyme involved in folate synthesis. Recently, the results of a study to identify targets for chemotherapy with use of molecular biological techniques have been reported (Gooze et al., 1991) . The thymydilate synthase-dihydrofolate reductase gene, which encodes the enzymatic target of pyrimethamine, has been cloned and sequenced. To our knowledge, protein synthesis inhibitors like macrolides have not been shown to potentiate the effect of agents that interfere with folate synthesis when tested against bacteria, and the interaction between pyrimethamine and macrolides against C. parvum needs to be clarified.
Further research is needed to characterize in more detail the mode of action of antimicrobial agents on C. parvum, to identify more active compounds and to clarify the molecular mechanisms of any possible synergy. Since parasite eradication has not yet been achieved with any agent tested alone or in combination, further studies with improved in-vitro cultivation systems need to be performed to compare the efficacy of macrolides and other antimicrobial agents against C. parvum.
